Want to join the conversation?
$REGN 2Q15 Call: Pivotal Phase 3 studies in the atopic dermatitis indication are fully enrolled and the company expects to report data from these studies in 1H16. Second pivotal study of Dupilumab in asthma is currently enrolling patients. This Phase 3 study will explore two doses of Dupilumab, 200 and 300 mg administered every other week.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.
Trivago N.V. (TRVG) announced today that it will release its financial results for the first quarter for the period ended March 31, 2017 on Monday, May 15, 2017. On the same day, trivago N.V.`s management will conduct a webcast beginning at 2:00 PM CET / 8:00 AM Eastern Time. These items will be available in the Investor Relations section of the company`s website at http://ir.trivago.com.
$VZ strikes again. After a depressing quarter, Verizon has jumped into action by launching its ultrafast competitor to Google Fiber - FiOS Gigabit Connection.